AI Platform Matches Patients to Trials

Patients and carers have increased ability to find out about and self select in clinical trials around the world, following the launch of Opin, an Australian developed platform that incorporates novel artificial intelligence and predictive analytics technology.

Improving efficiencies in research, creating greater equity, access and opportunities for patients to become more empowered in their health management is our goal.” – Michelle Gallaher, Chief Executive Officer of Opyl.

This is only an excerpt. The original article was written by mivision and the full version can be found here.